Top compounds associated with response to SLITRK6


Feature Type Standardized
Nominal ANOVA
mRNA BRD9876 CTRPv2 pan-cancer AAC 0.12 0.003
mRNA CUDC-101 GDSC1000 pan-cancer AAC 0.094 0.003
mRNA lapatinib CCLE pan-cancer AAC 0.14 0.003
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.004
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.11 0.004
mRNA RO4929097 CTRPv2 pan-cancer AAC 0.16 0.004
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC 0.099 0.005
mRNA SNX-2112 GDSC1000 pan-cancer AAC 0.085 0.005
mRNA CAY10603 GDSC1000 pan-cancer AAC 0.085 0.006
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.098 0.007
Download CSV